Navigation Links
Update: SpineMark Expands Management Team to Build Spine Care Network
Date:10/19/2007

SAN DIEGO, Oct. 19 /PRNewswire/ -- This press release updates a previous press release issued Monday, October 15, by SpineMark Corporation over PR Newswire.

SpineMark Corp., a medical management company that is building a network of Spine Centers of Excellence to support and connect physicians, facilities and medical device companies in order to provide patients the best spine care, announced today the appointments of Alan Donald, M.S., M.B.A., R.A.C. as president of SpineMark CRO Management Inc. and Alan Iftiniuk as interim chief operating officer of SpineMark Corporation.

"Our goal at SpineMark is to bring together physicians, hospitals and device companies to deliver the most advanced spine care to patients," said Marcy Rogers, president and CEO of SpineMark Corp. "These individuals bring more than 50 years of combined experience in healthcare business development and management and will help us integrate spine care clinical research and maximize financial and operational potential for physicians and institutions."

Mr. Donald combines medical research, business development and international regulatory sciences to drive products from the bench to commercialization. Over the past 25 years, he has advised more than 200 companies across four continents on the approval of biologics, drugs, diagnostics and medical devices. In his role as president of SpineMark CRO Management, Mr. Donald will work with medical device companies and physicians within the SpineMark network to establish clinical trial programs that offer patients the most advanced spine care.

"SpineMark has created a unique network of physicians, research institutions and medical device companies that are working together to provide the future of spine care," said Mr. Donald. "This exclusive network advances spine care by providing new tools and solutions in clinical research to improve the quality of life for patients suffering from spine conditions."

Mr. Iftiniuk brings more than 25 years of experience in hospital management and healthcare consulting to SpineMark. He has been an industry leader in growing and restructuring both commercial and non-profit hospital- based entities to meet financial and quality of care objectives. In his role as interim chief operating officer of SpineMark Corporation, Mr. Iftiniuk will oversee SpineMark's Centers of Excellence and help to create institutions which are both fiscally responsible as well as leaders in innovative spine care. In addition to his role with SpineMark, Alan is currently the President and Chief Executive Officer of French Hospital Medical Center in San Louis Obispo, California, a Catholic Healthcare West (CHW) facility. In 1999, as CEO of Good Shepherd Hospital in Barrington Ill., Alan built a successful NeuroSpine Center of Excellence and Wellness center with SpineMark's support and guidance.

"Having been on the hospital side, I am looking forward to using that experience to help SpineMark's Centers of Excellence meet financial and quality of care objectives that will dramatically improve quality of care and patient satisfaction," commented Mr. Iftiniuk. "We are ultimately interested in bringing the best spine care to patients while also creating a sustainable business for our affiliate physicians and institutions."

About SpineMark

SpineMark Corporation, headquartered in San Diego, combines the clinical, business development, contracting, marketing and research expertise to establish Spine Centers of Excellence. Additionally, SpineMark's subsidiary, SpineMark CRO Management Inc., conducts national FDA trials at the Centers of Excellence. Formed as a joint venture between Texas Back Institute Holdings and Management Technology Resources, SpineMark is dedicated to unite all of the necessary experience and expertise under the management of recognized leaders in both the business and medical world of spine care. To learn more about SpineMark, visit: http://www.spinemark.com.


'/>"/>
SOURCE SpineMark Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. The Cleveland Clinic Expands Its Services across the World via the Net
2. Ranbaxy Expands By Acquiring A Generic Company In Belgium
3. Insulin and Growth Hormone, Expands Life Span?
4. Health Insurance Company Expands Product Range
5. Bird Flu Outbreak Expands in Vietnam
6. New Modality in Migraine Management
7. Self-Management Program Beneficial for Back Pain
8. Self-Management Program Beneficial for Back Pain
9. Disease Management Programs – Effective for Heart Patient
10. Effective Management Of Heart Patients
11. New advance in prostate cancer management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... ... June 23, 2017 , ... The Rhode Island ... Care Management Alerts and Dashboards, an innovative new service enabling healthcare providers to ... Care Management Alerts and Dashboards provide near real-time data about patients admitted to ...
(Date:6/23/2017)... ... ... Studies show evidence that carotenoids and antioxidants derived either from the diet or ... But how often do ophthalmologists and optometrists in Sweden recommend the use of nutritional ... early symptoms of AMD? A study published recently in Dove Medical Press ...
(Date:6/23/2017)... ... June 23, 2017 , ... Everybody has their own personal preference when it ... it, and some people don't like it at all. FindaTopDoc took a look at ... Erotic literature can give readers a taste of their deepest, darkest fantasies and has ...
(Date:6/23/2017)... ... June 23, 2017 , ... Georgia State University will ... 20. , The two-day conference is focused on advancing scientific knowledge about the ... lives and eliminating racial breast cancer-related disparities. The conference theme is “Illuminating Actionable ...
(Date:6/23/2017)... , ... June 23, 2017 , ... ... Private Flood Insurance offerings. With the Federal Emergency Management Agency’s (FEMA) recent update ... the United States. In 2012, the Biggert-Waters Act was enacted to reflect the ...
Breaking Medicine News(10 mins):
(Date:6/3/2017)... 2017  Eli Lilly and Company (NYSE: ... the Phase 3 MONARCH 2 study showed that ... in combination with fulvestrant, significantly improved progression-free survival ... women with hormone-receptor-positive (HR+), human epidermal growth factor ... relapsed or progressed after endocrine therapy (median PFS, ...
(Date:5/30/2017)... 2017 Therapix Biosciences Ltd. (Nasdaq: TRPX), ... the development of cannabinoid-based drugs, today announced that ... at three upcoming scientific and investor conferences in ... Invitational: ...                     Wednesday, June ...
(Date:5/23/2017)...  Leaf Healthcare, recognized for developing one of ... ulcer prevention, will unveil its comprehensive mobility monitoring ... Nurses, National Teaching Institute and Critical Care Exposition ... Patient Monitoring System is the first mobility monitoring ... system seamlessly tracks patient movement throughout the mobility ...
Breaking Medicine Technology: